Case ReportCase Studies

Particulate Study on NeoProfen, a Neonatal Injectable Product

Aravind Krishna, Michael Rice, Tom Kester, Michael Waters and Terry Wilson
PDA Journal of Pharmaceutical Science and Technology January 2016, 70 (1) 76-92; DOI: https://doi.org/10.5731/pdajpst.2015.005587

Article Information

vol. 70 no. 1 76-92
DOI 
https://doi.org/10.5731/pdajpst.2015.005587
PubMed 
26889056
Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Published online February 16, 2016.
Copyright & Usage 
© PDA, Inc. 2016

Author Information

  1. Aravind Krishna1,
  2. Michael Rice1,
  3. Tom Kester2,
  4. Michael Waters2 and
  5. Terry Wilson*
  1. 1Marathon Pharmaceuticals, Northbrook, IL; and
  2. 2Recordati Rare Diseases, Lebanon, NJ
  1. ↵* Corresponding author: Ft. Orange Pharmaceutical Consulting, 402 Ontario St., Albany, NY 12208; telephone: 518-489-4189; e-mail: tdwilson111{at}yahoo.com

  1. This paper was presented in part as a poster at Hot Topics conference December 8–10, 2014, in Washington, DC.

View Full Text

Cited By...

Back to top

In This Issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Particulate Study on NeoProfen, a Neonatal Injectable Product
Aravind Krishna, Michael Rice, Tom Kester, Michael Waters, Terry Wilson
PDA Journal of Pharmaceutical Science and Technology Jan 2016, 70 (1) 76-92; DOI: 10.5731/pdajpst.2015.005587
Twitter logo Facebook logo Mendeley logo

Jump to section